Surgical aspects of gastrinoma in multiple endocrine neoplasia type 1.
Gastrinoma is the most frequent functional pancreaticoduodenal endocrine tumor in patients with multiple endocrine neoplasia type 1 (MEN1) and one major determinant of mortality in this syndrome. Whether routine surgical exploration should be performed in a patient with MEN1 associated Zollinger-Ellison syndrome (ZES) to possibly reduce the malignant spread and eventually increase survival still remains controversial. There is not only disagreement about the indication for surgical exploration, but also what type of procedure should be performed, since sufficient evidence-based data are not available. The article discusses the available data on treatment strategies of MEN1 associated ZES.
Bartsch
Detlef K
DK
Klinik für Allgemein- und Viszeralchirurgie der Städt. Kliniken Bielefeld-Mitte, Bielefeld, Germany. bartsch.detlef@sk-bielefeld.de
Langer
Peter
P
Rothmund
Matthias
M
D018450:Disease Progression; D004379:Duodenal Neoplasms / Q000097:blood / Q000401:mortality / Q000601:surgery*; D015408:Gastrinoma / Q000097:blood / Q000401:mortality / Q000601:surgery*; D005755:Gastrins / Q000097:blood*; D006801:Humans; D010535:Laparoscopy; D018761:Multiple Endocrine Neoplasia Type 1 / Q000097:blood / Q000401:mortality / Q000601:surgery*; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000097:blood / Q000401:mortality / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D011379:Prognosis; D012086:Reoperation; D015996:Survival Rate; D015043:Zollinger-Ellison Syndrome / Q000097:blood / Q000401:mortality / Q000601:surgery
D005755:Gastrins